Legal woes, decline in sales hurt Sun Pharma, but analysts find stock attractive

Here are the key takeaways from Sun Pharma’s June quarter earnings.

 
– Stocks-Markets-Economic Times

• Share on Facebook
• Tweet it
• Pin it
• Share it
• Email